CCTC EXAM – CERTIFIED CLINICAL TRANSPLANT COORDINATOR Complete Practice Test Bank |
300 Exam-Style Questions with Verified Answers & Detailed Rationales | All Core Domains
Covered | A+ Graded
TABLE OF CONTENTS
| Section | Domain | Questions |
|---------|-------|-----------|
| Exam Overview | Test Format, Blueprint, and Study Strategies | — |
| Section 1 | Transplant Immunology & Rejection | 1–50 |
| Section 2 | Pre-Transplant Evaluation & Waitlist Management | 51–100 |
| Section 3 | Deceased & Living Donor Management | 101–150 |
| Section 4 | Organ-Specific Transplantation | 151–200 |
| Section 5 | Post-Transplant Management & Complications | 201–250 |
| Section 6 | Pharmacology & Immunosuppression | 251–280 |
| Section 7 | Ethics, Legal Issues & Professional Practice | 281–300 |
---
EXAM OVERVIEW
Certified Clinical Transplant Coordinator (CCTC) Examination
The CCTC certification is a professional credential for healthcare professionals who specialize in
organ transplantation coordination. The certification is administered by the American Board for
Transplant Certification (ABTC) and validates expertise in managing the clinical, administrative,
and educational aspects of organ transplantation.
,Exam Format
| Feature | Details |
|---------|---------|
| Administering Body | American Board for Transplant Certification (ABTC) |
| Total Questions | 150 scored + 25 unscored = 175 total |
| Time Limit | 3 hours |
| Eligibility | 12 months of clinical vascular organ coordinator work experience |
| Cost | $495 exam fee + $150 nonrefundable application fee |
| Passing Score | Determined by ABTC (pass/fail report) |
| Retake Policy | Once every 90 days; after 3 failures, must complete 20 CEPTCs |
| Renewal | Every 3 years; 60 CEPTCs or retake exam |
Exam Content Domains
The CCTC exam covers transplant coordination across all vascular organs: kidney, pancreas, liver,
lung, intestine, and heart, including multi-organ transplants.
| Domain | Key Topics |
|--------|------------|
| Transplant Immunology & Rejection | HLA matching, crossmatching, antibody-mediated
rejection, cellular rejection, immunosuppression mechanisms |
| Pre-Transplant Evaluation | Patient selection, listing criteria, psychosocial evaluation, financial
clearance, waitlist management |
| Donor Management | Deceased donor criteria, brain death, donation after cardiac death
(DCD), living donor evaluation |
,| Organ-Specific Transplantation | Kidney, pancreas, liver, lung, heart, intestine—unique
considerations for each |
| Post-Transplant Management | Immunosuppression, infection prevention, rejection
monitoring, long-term follow-up |
| Pharmacology | Calcineurin inhibitors, antimetabolites, mTOR inhibitors, corticosteroids,
induction agents |
| Ethics & Professional Practice | Organ allocation, informed consent, confidentiality, advocacy,
regulatory compliance |
How to Use This Study Guide
This comprehensive guide contains 300 exam-style questions organized by core domain. Each
question includes a realistic scenario, four answer choices, the correct answer, and a detailed
rationale.
---
SECTION 1: TRANSPLANT IMMUNOLOGY & REJECTION
Questions 1–50
---
Question 1
A patient who received a kidney transplant 3 months ago presents with a 2-day history of fever,
malaise, and a 20% rise in serum creatinine. The kidney allograft is tender on palpation. Which
type of rejection is most likely occurring?
- A) Hyperacute rejection
, - B) Acute cellular rejection
- C) Chronic rejection
- D) Antibody-mediated rejection
Answer: B
Rationale: Acute cellular rejection typically occurs within the first 3–6 months post-transplant
and presents with fever, graft tenderness, and rising creatinine. Hyperacute rejection occurs
within minutes to hours. Chronic rejection occurs months to years later. Antibody-mediated
rejection may also occur but often has a different clinical presentation.
---
Question 2
Hyperacute rejection of a transplanted organ is primarily mediated by:
- A) T lymphocytes
- B) B lymphocytes
- C) Preformed donor-specific antibodies
- D) Cytokines
Answer: C
Rationale: Hyperacute rejection is caused by preformed donor-specific antibodies (DSAs) that
react with the donor organ's vascular endothelium, leading to rapid thrombosis and necrosis.
This occurs within minutes to hours of reperfusion.
---
300 Exam-Style Questions with Verified Answers & Detailed Rationales | All Core Domains
Covered | A+ Graded
TABLE OF CONTENTS
| Section | Domain | Questions |
|---------|-------|-----------|
| Exam Overview | Test Format, Blueprint, and Study Strategies | — |
| Section 1 | Transplant Immunology & Rejection | 1–50 |
| Section 2 | Pre-Transplant Evaluation & Waitlist Management | 51–100 |
| Section 3 | Deceased & Living Donor Management | 101–150 |
| Section 4 | Organ-Specific Transplantation | 151–200 |
| Section 5 | Post-Transplant Management & Complications | 201–250 |
| Section 6 | Pharmacology & Immunosuppression | 251–280 |
| Section 7 | Ethics, Legal Issues & Professional Practice | 281–300 |
---
EXAM OVERVIEW
Certified Clinical Transplant Coordinator (CCTC) Examination
The CCTC certification is a professional credential for healthcare professionals who specialize in
organ transplantation coordination. The certification is administered by the American Board for
Transplant Certification (ABTC) and validates expertise in managing the clinical, administrative,
and educational aspects of organ transplantation.
,Exam Format
| Feature | Details |
|---------|---------|
| Administering Body | American Board for Transplant Certification (ABTC) |
| Total Questions | 150 scored + 25 unscored = 175 total |
| Time Limit | 3 hours |
| Eligibility | 12 months of clinical vascular organ coordinator work experience |
| Cost | $495 exam fee + $150 nonrefundable application fee |
| Passing Score | Determined by ABTC (pass/fail report) |
| Retake Policy | Once every 90 days; after 3 failures, must complete 20 CEPTCs |
| Renewal | Every 3 years; 60 CEPTCs or retake exam |
Exam Content Domains
The CCTC exam covers transplant coordination across all vascular organs: kidney, pancreas, liver,
lung, intestine, and heart, including multi-organ transplants.
| Domain | Key Topics |
|--------|------------|
| Transplant Immunology & Rejection | HLA matching, crossmatching, antibody-mediated
rejection, cellular rejection, immunosuppression mechanisms |
| Pre-Transplant Evaluation | Patient selection, listing criteria, psychosocial evaluation, financial
clearance, waitlist management |
| Donor Management | Deceased donor criteria, brain death, donation after cardiac death
(DCD), living donor evaluation |
,| Organ-Specific Transplantation | Kidney, pancreas, liver, lung, heart, intestine—unique
considerations for each |
| Post-Transplant Management | Immunosuppression, infection prevention, rejection
monitoring, long-term follow-up |
| Pharmacology | Calcineurin inhibitors, antimetabolites, mTOR inhibitors, corticosteroids,
induction agents |
| Ethics & Professional Practice | Organ allocation, informed consent, confidentiality, advocacy,
regulatory compliance |
How to Use This Study Guide
This comprehensive guide contains 300 exam-style questions organized by core domain. Each
question includes a realistic scenario, four answer choices, the correct answer, and a detailed
rationale.
---
SECTION 1: TRANSPLANT IMMUNOLOGY & REJECTION
Questions 1–50
---
Question 1
A patient who received a kidney transplant 3 months ago presents with a 2-day history of fever,
malaise, and a 20% rise in serum creatinine. The kidney allograft is tender on palpation. Which
type of rejection is most likely occurring?
- A) Hyperacute rejection
, - B) Acute cellular rejection
- C) Chronic rejection
- D) Antibody-mediated rejection
Answer: B
Rationale: Acute cellular rejection typically occurs within the first 3–6 months post-transplant
and presents with fever, graft tenderness, and rising creatinine. Hyperacute rejection occurs
within minutes to hours. Chronic rejection occurs months to years later. Antibody-mediated
rejection may also occur but often has a different clinical presentation.
---
Question 2
Hyperacute rejection of a transplanted organ is primarily mediated by:
- A) T lymphocytes
- B) B lymphocytes
- C) Preformed donor-specific antibodies
- D) Cytokines
Answer: C
Rationale: Hyperacute rejection is caused by preformed donor-specific antibodies (DSAs) that
react with the donor organ's vascular endothelium, leading to rapid thrombosis and necrosis.
This occurs within minutes to hours of reperfusion.
---
